IGF2BP3 Antikörper (AA 101-230)
-
- Target Alle IGF2BP3 Antikörper anzeigen
- IGF2BP3 (Insulin-Like Growth Factor 2 mRNA Binding Protein 3 (IGF2BP3))
-
Bindungsspezifität
- AA 101-230
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser IGF2BP3 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Kreuzreaktivität
- Human, Maus, Ratte
- Homologie
- Dog,Horse
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human Insulin-like growth factor 2 mRNA-binding protein 3
- Isotyp
- IgG
- Top Product
- Discover our top product IGF2BP3 Primärantikörper
-
-
- Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- IGF2BP3 (Insulin-Like Growth Factor 2 mRNA Binding Protein 3 (IGF2BP3))
- Andere Bezeichnung
- IGF2BP3 (IGF2BP3 Produkte)
- Synonyme
- CT98 antikoerper, IMP-3 antikoerper, IMP3 antikoerper, KOC1 antikoerper, VICKZ3 antikoerper, Ab2-255 antikoerper, RGD1306512 antikoerper, imp3 antikoerper, koc1 antikoerper, vera antikoerper, imp-3 antikoerper, vg1rbp antikoerper, vickz3 antikoerper, 2610101N11Rik antikoerper, AA522010 antikoerper, AL022933 antikoerper, AU045931 antikoerper, Koc13 antikoerper, Neilsen antikoerper, mimp3 antikoerper, dvr1rbp antikoerper, wu:fb79c12 antikoerper, wu:fe06h09 antikoerper, zVg1RBP antikoerper, B3 antikoerper, IGF2 mRNA-binding protein 3-B antikoerper, IMP antikoerper, IMP-3-B antikoerper, Vg1 RBP-B antikoerper, Vg1-RBP antikoerper, igf2bp3 antikoerper, igf2bp3-a antikoerper, igf2bp3-b antikoerper, IGF2 mRNA-binding protein 3-A antikoerper, IMP-3-A antikoerper, Vg1 RBP-A antikoerper, vera-A antikoerper, insulin like growth factor 2 mRNA binding protein 3 antikoerper, insulin-like growth factor 2 mRNA binding protein 3 antikoerper, insulin like growth factor 2 mRNA binding protein 3 S homeolog antikoerper, insulin like growth factor 2 mRNA binding protein 3 L homeolog antikoerper, IGF2BP3 antikoerper, Igf2bp3 antikoerper, igf2bp3 antikoerper, igf2bp3.S antikoerper, igf2bp3.L antikoerper
- Hintergrund
-
Synonyms: KOC, CT98, IMP3, KOC1, IMP-3, VICKZ3, Insulin-like growth factor 2 mRNA-binding protein 3, IGF2 mRNA-binding protein 3, IGF-II mRNA-binding protein 3, KH domain-containing protein overexpressed in cancer, hKOC, VICKZ family member 3, IGF2BP3
Background: RNA-binding factor that may recruits target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation. Binds to the 3'-UTR of CD44 mRNA and stabilizes it, hence promotes cell adhesion and invadopodia formation in cancer cells. Binds to beta-actin/ACTB and MYC transcripts. Binds to the 5'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs.
- Gen-ID
- 10643
- UniProt
- O00425
-